Medfinder
Back to blog

Updated: January 15, 2026

Why is Rexulti so hard to find? [Explained for 2026]

Author

Peter Daggett

Peter Daggett

Pharmacist looking at empty specialty medication shelf

Rexulti isn't on an FDA shortage list, so why is it so hard to find at your pharmacy? We break down the real reasons patients struggle to fill their Rexulti prescriptions in 2026.

You have a valid Rexulti prescription. You've tried two pharmacies already. One says it'll be a week. The other doesn't carry it at all. Sound familiar?

You're not alone — and you're not imagining it. Many patients on Rexulti (brexpiprazole) report frustrating delays filling their prescriptions, even though the drug isn't technically listed on the FDA's official shortage database. So what's actually going on?

Is Rexulti actually in a shortage?

Technically, no. Rexulti is not listed on the FDA's official drug shortage list as of 2026. That means the manufacturer, Otsuka Pharmaceutical (in partnership with Lundbeck), is producing enough of the drug to meet overall national demand.

But "no shortage" at a national level doesn't mean your local CVS, Walgreens, or independent pharmacy has it on the shelf. There are several reasons why Rexulti can be genuinely difficult to locate, and they have nothing to do with a manufacturing crisis.

Reason 1: Rexulti is a brand-name specialty medication

Unlike common generic drugs that cost a few dollars and are ordered by the case, Rexulti carries a list price of around $1,500 per month. That high cost changes the way pharmacies manage their inventory.

Pharmacies — especially smaller independents — can't afford to keep expensive brand-name drugs on the shelf speculatively. They typically order Rexulti only when a specific patient needs it, on a just-in-time basis. If the wholesaler's regional warehouse is temporarily out, you wait. If the order was missed by a day, you wait. This is the hidden friction behind countless "we'll have it in a few days" responses.

Reason 2: No generic means no competition — and tighter distribution

There is currently no widely available generic version of Rexulti. While the FDA approved a generic from Alembic Pharmaceuticals in early 2025, active patent protections held by Otsuka and Lundbeck are expected to block broad commercial availability for years to come — potentially until 2032 or 2033.

When a drug is available only in brand-name form, there's just one manufacturer and a narrower distribution pipeline. There are no competing generics to fill the gaps when a regional wholesaler runs low, and pharmacies have fewer options for sourcing the drug quickly.

Reason 3: Not every pharmacy stocks every strength

Rexulti comes in six strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg. A pharmacy might reliably stock 2 mg tablets — the most commonly prescribed dose — but may not routinely carry 0.25 mg or 3 mg.

If your prescription is for a less common dose, you may find yourself calling multiple pharmacies before locating your specific strength. This is especially common during titration, when providers start patients on lower doses before moving up.

Reason 4: Insurance and prior authorization delays

Many insurance plans — including Medicare Part D and commercial plans — require prior authorization before covering Rexulti. Some plans also require step therapy, meaning you must first "fail" on cheaper medications before they'll approve Rexulti.

While this isn't a pharmacy stock issue, it creates a cycle that patients experience as the prescription being "unavailable" — because the claim keeps getting rejected at the counter. According to GoodRx data, roughly 83% of insurance plans cover Rexulti, but many of those plans have significant restrictions attached.

Reason 5: Small and rural pharmacies may not carry it at all

Rexulti is most reliably found at large chain pharmacies — CVS, Walgreens, Rite Aid, and large grocery chains with pharmacy departments. Smaller independent pharmacies, especially in rural areas, may not carry it at all, or only order it on request.

If you live in a rural area or rely on a local independent pharmacy, this is a significant obstacle. Your pharmacist may mean well, but if their wholesaler relationship doesn't easily supply Rexulti, there's a real logistics gap.

What can you do if you can't find Rexulti?

The good news: there are real solutions. Here's what we recommend:

  • Use Medfinder. Medfinder checks real-time pharmacy inventory so you can locate which nearby pharmacies have your strength in stock without calling around yourself.
  • Ask about mail-order. Mail-order pharmacies often have better access to specialty brand-name medications and can deliver a 90-day supply directly to your door.
  • Contact your prescriber. If your insurance is the problem (prior auth, step therapy), your provider can often help by submitting the right documentation or filing a formulary exception.
  • Explore alternatives. If ongoing availability is a concern, talk to your provider about whether a similar medication with better pharmacy access might work for you. Read our guide to Rexulti alternatives for more.

The bottom line

Rexulti isn't in an official FDA shortage, but the combination of high cost, brand-only status, no generic competition, and demand for specific dosage strengths creates a perfect storm for pharmacy availability headaches. Understanding why is the first step. Then check out our Rexulti shortage update for 2026 for the latest information on availability trends and what's being done.

Frequently Asked Questions

No, Rexulti is not listed on the FDA's official drug shortage database as of 2026. However, individual pharmacies — especially smaller ones — may not stock it consistently due to its high cost and brand-only status.

Most pharmacies order expensive brand-name drugs like Rexulti only when a patient needs it, rather than keeping a standing supply. If the wholesaler is temporarily low or the order was delayed, you may wait a few days. Calling ahead or using Medfinder to check real-time inventory can help.

The FDA approved a generic (brexpiprazole) from Alembic Pharmaceuticals in early 2025, but active patents held by Otsuka and Lundbeck are expected to block broad market availability potentially until 2032 or 2033. Generics are not yet widely available at pharmacies.

Lower titration doses like 0.25 mg and 0.5 mg and higher doses like 3 mg can be harder to find because they're ordered less frequently. The 2 mg tablet is typically the most stocked. Call your pharmacy before transferring your prescription if you take a less common strength.

Use Medfinder to check real-time pharmacy inventory near you, ask about mail-order options, contact your prescriber about insurance barriers, or ask whether a comparable alternative medication might be appropriate for your situation.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Rexulti also looked for:

29,490 have already found their meds with Medfinder.

Start your search today.

29K+
5-star ratingTrusted by 29,490 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?